Pharma 2023: Nuevas drogas que se lanzarán y aprobarán desde Agosto 2023 en Adelante. Sus proyecciones.

Las Drogas que se lanzarán en 2023 desde Agosto en Adelante.

Descargue el Excel aqui: 

COMPANY COUNTRY CURRENCY MARKET CAP (Bn) CHANGE IN MARKET CAP (M) STOCK PRICE CHANGE IN PRICE
PeptiDream (4587.T) Japan JPY 234,48 -45.570 1.833 -16,1%
Merck & Co (MRK) U.S.A USD 267,88 -20.320 107 -7,0%
Apellis Pharmaceuticals (APLS) U.S.A USD 4,01 -6.871 32 -64,8%
Eli Lilly (LLY) U.S.A USD 426,66 -6.645 459 -1,5%
Bristol Myers Squibb (BMY) U.S.A USD 130,13 -6.300 62 -4,6%
Pfizer Inc (PFE) U.S.A USD 202,44 -5.650 36 -2,7%
Takeda Pharmaceutical (TAK) Japan USD 48,11 -3.110 15 -6,3%
Biogen (BIIB) U.S.A USD 40,37 -1.882 273 -4,5%
Moderna Therapeutics (MRNA) U.S.A USD 46,74 -1.525 119 -3,3%
Vir Biotechnology (VIR) U.S.A USD 3,09 -1.474 14 -44,0%
NovoCure (NVCR) U.S.A USD 3,54 -850 35 -18,6%
Horizon Therapeutics (HZNP) Ireland USD 23,16 -686 100 -2,9%
TG Therapeutics (TGTX) U.S.A USD 3,21 -598 21 -16,0%
Sarepta Therapeutics (SRPT) U.S.A USD 9,84 -466 109 -4,4%
Mirati Therapeutics (MRTX) U.S.A USD 2,01 -466 31 -20,5%
Madrigal Pharmaceuticals (MDGL) U.S.A USD 3,95 -439 208 -10,3%
Mersana Therapeutics (MRSN) U.S.A USD 0,14 -343 1 -75,0%
Alkermes Plc (ALKS) Ireland USD 4,78 -332 29 -6,5%
Theseus Pharmaceuticals (THRX) U.S.A USD 0,13 -305 3 -70,0%
Biohaven Pharmaceuticals (BHVN) U.S.A USD 1,62 -273 20 -16,7%
Akero Therapeutics (AKRO) U.S.A USD 2,52 -221 43 -8,5%
Seagen (SGEN) U.S.A USD 37,05 -188 193 -0,5%
Vaxcyte (PCVX) U.S.A USD 4,55 -187 48 -4,0%
Pacira BioSciences (PCRX) U.S.A USD 1,74 -184 36 -10,0%
Stoke Therapeutics (STOK) U.S.A USD 0,29 -177 7 -36,4%
Ventyx Biosciences (VTYX) U.S.A USD 2,08 -176 38 -7,3%
Replimune (REPL) U.S.A USD 1,20 -173 21 -12,5%
Ambrx Inc (AMAM) U.S.A USD 0,89 -121 15 -11,8%
Cytokinetics (CYTK) U.S.A USD 3,34 -96 33 -2,9%
Mineralys Therapeutics (MLYS) U.S.A USD 0,63 -82 15 -11,8%
Vigil Neuroscience (VIGL) U.S.A USD 0,26 -71 8 -20,0%
AEON Biopharma (AEON) U.S.A USD 0,16 -64 9 -25,0%
Emergent BioSolutions (EBS) U.S.A USD 0,40 -50 7 -12,5%
VBI Vaccines (VBIV) U.S.A USD 0,03 -46 1 -66,7%
Icosavax (ICVX) U.S.A USD 0,39 -41 9 -10,0%
Apogee Therapeutics (APGE) U.S.A USD 0,99 -34 21 -4,5%
Bicycle Therapeutics (BCYC) United Kingdom USD 0,79 -30 25 -3,8%
Tonix Pharmaceuticals Holding Corp (TNXP) U.S.A USD 0,01 -10 1 -50,0%
ADC Therapeutics (ADCT) Switzerland USD 0,12 0 2 0,0%
Astellas Pharma (ALPMY) Japan USD 26,53 0 15 0,0%
Beam Therapeutics (BEAM) U.S.A USD 2,35 0 32 0,0%
Biomea Fusion (BMEA) U.S.A USD 0,81 0 22 0,0%
Catalyst Pharmaceuticals (CPRX) U.S.A USD 1,44 0 14 0,0%
Generation Bio (GBIO) U.S.A USD 0,33 0 5 0,0%
Gilead Sciences (GILD) U.S.A USD 96,28 0 77 0,0%
Gossamer Bio (GOSS) U.S.A USD 0,12 0 1 0,0%
GSK (GSK) United Kingdom USD 70,78 0 36 0,0%
Hansoh Pharma (3692.HK) China HKD 75,24 0 13 0,0%
Intra-Cellular Therapies (ITCI) U.S.A USD 6,09 0 63 0,0%
Ionis Pharmaceuticals (IONS) U.S.A USD 5,69 0 42 0,0%
Mirum Pharmaceuticals (MIRM) U.S.A USD 0,96 0 26 0,0%
Paratek Pharmaceuticals (PRTK) U.S.A USD 0,12 0 2 0,0%
Poseida Therapeutics, Inc (PSTX) U.S.A USD 0,16 0 2 0,0%
Prothena (PRTA) Ireland USD 3,38 0 69 0,0%
PTC Therapeutics (PTCT) U.S.A USD 3,04 0 42 0,0%
Sangamo Therapeutics (SGMO) U.S.A USD 0,23 0 1 0,0%
Sanofi (SNY) France USD 132,25 0 54 0,0%
Santhera Pharmaceuticals (SANN.SW) Switzerland CHF 0,10 0 9 0,0%
Silence Therapeutics (SLNCF) United Kingdom USD 0,09 0 1 0,0%
Synaptogenix (SNPX) U.S.A USD 0,01 0 1 0,0%
Cabaletta Bio (CABA) U.S.A USD 0,60 40 14 7,7%
4D Molecular Therapeutics (FDMT) U.S.A USD 0,75 42 19 5,6%
Crinetics Pharmaceuticals (CRNX) U.S.A USD 1,01 54 19 5,6%
Phathom Pharmaceuticals (PHAT) U.S.A USD 0,80 56 16 6,7%
Novavax (NVAX) U.S.A USD 0,70 86 9 12,5%
Amphastar Pharmaceuticals (AMPH) U.S.A USD 2,70 97 61 3,4%
Nanobiotix (NBTX) France USD 0,32 105 8 60,0%
Castle Biosciences (CSTL) U.S.A USD 0,43 107 18 28,6%
Acumen Pharmaceuticals (ABOS) U.S.A USD 0,26 123 8 60,0%
Travere Therapeutics (TVTX) U.S.A USD 1,18 149 18 12,5%
Evelo Biosciences (EVLO) U.S.A USD 0,22 150 11 266,7%
Tarsus Pharmaceuticals (TARS) U.S.A USD 0,66 161 24 33,3%
Kiniksa Pharmaceuticals (KNSA) U.S.A USD 1,36 175 19 35,7%
BioMarin Pharmaceutical (BMRN) U.S.A USD 16,12 188 88 1,1%
Centessa Pharmaceuticals (CNTA) U.S.A USD 0,76 191 8 33,3%
BioNTech (BNTX) Germany USD 26,09 241 110 0,9%
Blueprint Medicines (BPMC) U.S.A USD 3,48 242 68 6,3%
Neuren Pharmaceuticals (NEU.AX) Australia AUD 1,77 258 14 16,7%
Caribou Biosciences (CRBU) U.S.A USD 0,42 264 8 100,0%
UroGen Pharma (URGN) U.S.A USD 0,53 281 22 120,0%
SpringWorks Therapeutics (SWTX) U.S.A USD 1,87 313 32 18,5%
Bio-Techne (TECH) U.S.A USD 14,08 315 84 2,4%
Immunocore (IMCR) United Kingdom USD 2,93 370 67 13,6%
Jazz Pharmaceuticals (JAZZ) Ireland USD 8,09 385 131 4,8%
Nuvalent (NUVL) U.S.A USD 2,45 411 50 19,0%
Immunovant (IMVT) U.S.A USD 3,13 522 23 21,1%
Evotec (EVO) Germany USD 4,74 708 13 18,2%
Neurocrine Biosciences (NBIX) U.S.A USD 9,37 878 104 9,5%
Halozyme Therapeutics (HALO) U.S.A USD 5,03 922 44 18,9%
United Therapeutics (UTHR) U.S.A USD 10,98 937 245 8,9%
Acadia Pharmaceuticals (ACAD) U.S.A USD 5,23 976 30 25,0%
Recursion Pharma (RXRX) U.S.A USD 2,58 1.108 14 75,0%
Alnylam Pharmaceuticals (ALNY) U.S.A USD 24,54 1.245 200 5,3%
Legend Biotech (LEGN) U.S.A USD 12,63 1.262 76 10,1%
Vertex Pharmaceuticals (VRTX) U.S.A USD 92,20 1.288 354 1,4%
Roivant Sciences (ROIV) U.S.A USD 8,94 1.534 12 20,0%
Reata Pharmaceuticals (RETA) U.S.A USD 6,24 2.082 167 60,6%
Regeneron Pharmaceuticals (REGN) U.S.A USD 79,17 2.481 745 3,2%
Genmab (GMAB) Denmark USD 26,12 2.611 42 10,5%
BridgeBio Pharma (BBIO) U.S.A USD 5,48 2.889 36 100,0%
Bayer AG (BAYN.DE) Germany EUR 49,34 2.947 54 5,9%
BeiGene (BGNE) China USD 20,78 4.113 221 21,4%
Novo Nordisk (NVO) Denmark USD 360,66 4.480 162 1,3%
Amgen Inc (AMGN) U.S.A USD 121,52 5.343 236 4,4%
F. Hoffmann-La Roche (RHHBY) Switzerland USD 254,53 6.390 39 2,6%
argenx (ARGX) Netherlands USD 21,21 6.883 511 31,7%
Novartis Pharmaceuticals Corporation (NVS) Switzerland USD 209,71 10.600 105 5,0%
AstraZeneca (AZN) United Kingdom USD 208,86 15.500 72 7,5%
Johnson & Johnson (JNJ) U.S.A USD 413,38 15.600 170 3,7%
AbbVie Inc (ABBV) U.S.A USD 239,96 28.160 151 11,9%
Otsuka Holdings (4578.T) Japan JPY 2.815,00 104.728 5.507 3,6%